BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1604043)

  • 1. Bioavailability of ibuprofen from oral and suppository preparations in rats.
    Kaka JS; Tekle A
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):171-82. PubMed ID: 1604043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol.
    Yong CS; Oh YK; Jung SH; Rhee JD; Kim HD; Kim CK; Choi HG
    Eur J Pharm Sci; 2004 Dec; 23(4-5):347-53. PubMed ID: 15567287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
    Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
    Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of racemic ibuprofen and its lysinate from suppositories in rabbits.
    Hermann TW; Gtówka FK; Garrett ER
    J Pharm Sci; 1993 Nov; 82(11):1102-11. PubMed ID: 8289122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration.
    Kimura S; Imai T; Otagiri M
    Pharm Acta Helv; 1991; 66(4):120-4. PubMed ID: 1758897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
    Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
    Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
    Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus rectal ibuprofen in healthy volunteers.
    Vilenchik R; Berkovitch M; Jossifoff A; Ben-Zvi Z; Kozer E
    J Popul Ther Clin Pharmacol; 2012; 19(2):e179-86. PubMed ID: 23238355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
    Pargal A; Kelkar MG; Nayak PJ
    Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen.
    Ceppi Monti N; Gazzaniga A; Gianesello V; Stroppolo F; Lodola E
    Arzneimittelforschung; 1992 Apr; 42(4):556-9. PubMed ID: 1642682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a rectal suppository containing the antiepileptic drug zonisamide.
    Nagatomi A; Mishima M; Tsuzuki O; Ohdo S; Higuchi S
    Biol Pharm Bull; 1997 Aug; 20(8):892-6. PubMed ID: 9300137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
    Lamprecht A; Saumet JL; Roux J; Benoit JP
    Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules.
    Hannula AM; Marvola M; Rajamaeki M; Ojantakanen S
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():221-7. PubMed ID: 1820883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration.
    Kyllönen M; Olkkola KT; Seppälä T; Ryhänen P
    Paediatr Anaesth; 2005 Jul; 15(7):566-73. PubMed ID: 15960640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of ethionamide suppositories.
    Peloquin CA; James GT; McCarthy E; Goble M
    Pharmacotherapy; 1991; 11(5):359-63. PubMed ID: 1745621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.